Historical Stock Price
|
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACER Historical Stock Prices |
| Preferred Stock Newsletter |
| Top Option Ideas |
| Stock Message Boards |
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on October 17, 2019, ACER opened at $3.22, traded as high as $3.27 and as low as $3.03, and closed at $3.06. Trading volume was a total of 63.50K shares. On October 18, 2019, ACER opened at $3.24, traded as high as $3.32 and as low as $2.96, and closed at $3.00. Trading volume was a total of 51.80K shares. On October 21, 2019, ACER opened at $3.05, traded as high as $3.20 and as low as $3.03, and closed at $3.14. Trading volume was a total of 41.20K shares. On October 22, 2019, ACER opened at $3.14, traded as high as $3.47 and as low as $3.14, and closed at $3.38. Trading volume was a total of 75.00K shares. On October 23, 2019, ACER opened at $3.38, traded as high as $3.47 and as low as $3.14, and closed at $3.34. Trading volume was a total of 28.20K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 10/23/2009 | |
| End date: | 10/23/2019 | |
| Start price/share: | $24.17 | |
| End price/share: | $3.34 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -86.18% | |
| Average Annual Total Return: | -17.95% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $1,381.39 | |
| Years: | 10.01 | |
 | |||||
| ACER Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 10/17/2019 | $3.22 | $3.27 | $3.03 | $3.06 | 63.50K |
| 10/18/2019 | $3.24 | $3.32 | $2.96 | $3.00 | 51.80K |
| 10/21/2019 | $3.05 | $3.20 | $3.03 | $3.14 | 41.20K |
| 10/22/2019 | $3.14 | $3.47 | $3.14 | $3.38 | 75.00K |
| 10/23/2019 | $3.38 | $3.47 | $3.14 | $3.34 | 28.20K |
|
| About Acer Therapeutics |
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with unmet medical need. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a fully taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of various neuroendocrine disorders. |
| ACER Historical Closing Prices | |
| Date | Close |
| 10/17/2019 | $3.06 |
| 10/18/2019 | $3.00 |
| 10/21/2019 | $3.14 |
| 10/22/2019 | $3.38 |
| 10/23/2019 | $3.34 |
| Healthcare Historical Prices |
| ACER is categorized under the Healthcare sector; below are some other companies in the same sector:
ACET Historical Stock Prices Also explore: ACER shares outstanding history |
